Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit

HPV18 E7/Protein E7 ELISA Kit

Catalog #:   KVV08901 Specific References (50) DATASHEET
Sample type: Plasma, Serum
Sensitivity: 10.01 pg/mL
Range: 15.63 - 1,000 pg/mL
Overview

Catalog No.

KVV08901

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative (Sandwich)

Range

15.63 - 1,000 pg/mL

Sensitivity

10.01 pg/mL

Precision

CV<20%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Alternative Names

E7, Protein E7

Data Image
References

Evaluating HPV E6/E7 mRNA expression and genotype prevalence in cervical cytology and biopsy samples from Yunnan Province, China., PMID:40496315

Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides., PMID:40476553

Crosstalk Between the Oncoproteins of High-Risk Human Papillomaviruses Types 16 and 18 in Colorectal Cancer Cell Models., PMID:40468102

Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications., PMID:40431173

Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies., PMID:40403026

Human papillomavirus E1 proteins inhibit RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT signaling pathways to evade innate antiviral immunity., PMID:40330484

Human papilloma virus (HPV) mediated cancers: an insightful update., PMID:40301924

Human papillomavirus E2 proteins suppress innate antiviral signaling pathways., PMID:40264759

Unlocking the secrets: Exploring the connection between HPV and bladder cancer in Pakistan., PMID:40240277

The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer., PMID:40143337

Astragalin inhibits the proliferation of high-risk HPV-positive cervical epithelial cells and attenuates malignant cervical lesions., PMID:40124127

Drosophila model of HPV18-Induced pathogenesis reveals a role for E6 oncogene in regulation of NF-κB and Wnt to inhibit apoptosis., PMID:40074036

KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer., PMID:39989021

Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer., PMID:39815804

Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma: Structural, transcriptomic and in vitro insights., PMID:39807101

DARPin-induced reactivation of p53 in HPV-positive cells., PMID:39789211

Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation., PMID:39761277

Comparative efficacy of HPV 16/18 DNA and E6/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies., PMID:39733635

Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methods., PMID:39722048

Human Papillomavirus Infection and Autoimmune Diseases: A Two-Sample Bidirectional Mendelian Randomization Study., PMID:39618109

The Distribution of HR-HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer., PMID:39540331

The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer., PMID:39536909

Detection of transcriptionally active high-risk human papillomavirus in patients with oesophageal carcinoma by real-time PCR., PMID:39412909

Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells., PMID:39411320

PRMT1 Modulates Alternative Splicing to Enhance HPV18 mRNA Stability and Promote the Establishment of Infection., PMID:39386465

Molecular detection of high-risk papillomaviruses and vaccination status in normal cytology in Congo., PMID:39361924

Signaling pathways in HPV-induced cervical cancer: Exploring the therapeutic promise of RNA modulation., PMID:39357186

Enhanced Two-Step LAMP-CRISPR Assay with an Engineered Zst Polymerase for Contamination-Free and Ultrasensitive DNA Detection., PMID:39250834

HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14., PMID:39248565

HPV 16/18 E7 oncoprotein detection as a promising triage strategy for HPV 16/18-positive patients: A prospective multicenter study with a 2-year follow up., PMID:39244722

No genetic causal association between human papillomavirus and lung cancer risk: a bidirectional two-sample Mendelian randomization analysis., PMID:39227966

Microfluid biosensor for detection of hpv in patient scraping samples: Determining E6 and E7 oncogenes., PMID:39146929

HPV18 E6/E7 activates Ca2+ influx to promote the malignant progression of cervical cancer by inhibiting Ca2+ binding protein 1 expression., PMID:39113388

Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer., PMID:39039819

Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers., PMID:38978164

Genetic variability of human papillomavirus type 18 based on E6, E7 and L1 genes in central China., PMID:38970084

Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells., PMID:38967656

Quantification of HPV16 E7 Oncoproteins in Urine Specimens from Women with Cervical Intraepithelial Neoplasia., PMID:38930587

A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity., PMID:38926425

Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management., PMID:38884391

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector., PMID:38858404

Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies., PMID:38715363

An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort., PMID:38709462

HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer., PMID:38624210

Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva., PMID:38600473

Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status., PMID:38577820

Distribution of human papillomavirus among Vietnamese women with cervical cancer and unusual genetic variability of HPV16., PMID:38520797

Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies., PMID:38514186

HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14., PMID:38496413

HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice., PMID:38480731

Datasheet
$ 1128
Product specifications
96 T 1128

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

HPV18 E7/Protein E7 ELISA Kit [KVV08901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only